Advertisement

Neurological Sciences

, Volume 33, Issue 1, pp 9–15 | Cite as

Exercise and amyotrophic lateral sclerosis

  • J. P. Lopes de Almeida
  • R. Silvestre
  • A. C. Pinto
  • M. de Carvalho
Review Article

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a progressive and fatal neurodegenerative disease in which much burden is geared towards end-of-life care. Particularly in the earlier stages of ALS, many people have found both physiological and psychological boosts from various types of physical exercise for disused muscles. Proper exercise is important for preventing atrophy of muscles from disuse—a key for remaining mobile for as long as possible—and as long as it is possible to exercise comfortably and safely, for preserving cardiovascular fitness. However, the typical neuromuscular patient features a great physical inactivity and disuse weakness, and for that reason many controversial authors have contested exercise in these patients during years, especially in ALS which is rapidly progressive. There is an urgent need for dissecting in detail the real risks or benefits of exercise in controlled clinical trials to demystify this ancient paradigm. Yet, recent research studies document significant benefits in terms of survival and quality of life in ALS, poor cooperation, small sample size, uncontrolled and short-duration trials, remain the main handicaps. Sedentary barriers such as early fatigue and inherent muscle misuse should be overcome, for instance with body-weight supporting systems or non-invasive ventilation, and exercise should be faced as a potential non-monotonous way for contributing to better health-related quality of life.

Keywords

Amyotrophic lateral sclerosis Non-invasive ventilation Exercise 

Abbreviations

ALS

Amyotrophic lateral sclerosis

ALSFRS

Amyotrophic lateral sclerosis functional rate score

NIV

Non-invasive ventilation

Notes

Conflict of interest

No competing personal and financial interests exist to declare.

References

  1. 1.
    Rowland LP (2001) How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol 58:512–515PubMedCrossRefGoogle Scholar
  2. 2.
    Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688–1700PubMedCrossRefGoogle Scholar
  3. 3.
    Preux PM, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, Vallat JM, Dumas M, Boutros-Toni F (2000) Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol 53:1025–1029PubMedCrossRefGoogle Scholar
  4. 4.
    Kurtzke JF (1982) Epidemiology of amyotrophic lateral sclerosis. Adv Neurol 36:281–302PubMedGoogle Scholar
  5. 5.
    Kurtzke JF, Beebe GW (1980) Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology 30:453–462PubMedGoogle Scholar
  6. 6.
    Mandrioli J, Faglioni P, Merelli E, Sola P et al (2003) The epidemiology of ALS in Modena, Italy. Neurology 60:683–689PubMedGoogle Scholar
  7. 7.
    Brooks BR (1996) Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin 14:399–420PubMedCrossRefGoogle Scholar
  8. 8.
    Boillee S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39–59PubMedCrossRefGoogle Scholar
  9. 9.
    Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW et al (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389–1392PubMedCrossRefGoogle Scholar
  10. 10.
    Christensen PB, Hojer-Pedersen E, Jensen NB (1990) Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties. Neurology 40:600–604PubMedGoogle Scholar
  11. 11.
    Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV et al (2002) Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 25:709–714PubMedCrossRefGoogle Scholar
  12. 12.
    Eisen A, Kim S, Pant B (1992) Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve 15:219–224PubMedCrossRefGoogle Scholar
  13. 13.
    Eisen A, Nakajima M, Weber M (1999) Electrophysiological studies of the corticomotoneuron in ALS. Rinsho Shinkeigaku 39:99PubMedGoogle Scholar
  14. 14.
    Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Petropoulou O, Zis V, Sfagos C, Vassilopoulos D et al (2008) Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis. In Vivo 22:137–141PubMedGoogle Scholar
  15. 15.
    Bogaert E, d’Ydewalle C, Van Den Bosch L (2010) Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target. CNS Neurol Disord Drug Targets 9:297–304Google Scholar
  16. 16.
    Brighina L, Sala G, Ceresa C, Tremolizzo L, Ferrarese C et al (2001) Recent advances in the therapy of amyotrophic lateral sclerosis: focus on excitotoxicity. Funct Neurol 16:189–202PubMedGoogle Scholar
  17. 17.
    Cluskey S, Ramsden DB (2001) Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol Pathol 54:386–392PubMedGoogle Scholar
  18. 18.
    Goodall EF, Morrison KE (2006) Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev Mol Med 8:1–22PubMedCrossRefGoogle Scholar
  19. 19.
    (1997) Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 49:657–659Google Scholar
  20. 20.
    (1997) Riluzole for amyotrophic lateral sclerosis. Drug Ther Bull 35:11–12Google Scholar
  21. 21.
    Bensimon G, Lacomblez L, Meininger V et al (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330:585–591PubMedCrossRefGoogle Scholar
  22. 22.
    Takahashi H, Oyanagi K, Ikuta F, Tanaka M, Yuasa T, Miyatake T et al (1993) Widespread multiple system degeneration in a patient with familial amyotrophic lateral sclerosis. J Neurol Sci 120:15–21PubMedCrossRefGoogle Scholar
  23. 23.
    Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB et al (1993) Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 342:1016–1018PubMedCrossRefGoogle Scholar
  24. 24.
    Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806–819PubMedCrossRefGoogle Scholar
  25. 25.
    Siddique T (1996) ALS: molecular clues to the jigsaw puzzle of neuronal degeneration. Cold Spring Harb Symp Quant Biol 61:699–708PubMedCrossRefGoogle Scholar
  26. 26.
    Siddique T, Deng HX (1996) Genetics of amyotrophic lateral sclerosis. Hum Mol Genet 5 Spec No:1465–1470PubMedGoogle Scholar
  27. 27.
    Menzies FM, Grierson AJ, Cookson MR, Heath PR, Tomkins J, Figlewicz DA, Ince PG, Shaw PJ et al (2002) Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J Neurochem 82:1118–1128PubMedCrossRefGoogle Scholar
  28. 28.
    Menzies FM, Ince PG, Shaw PJ (2002) Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int 40:543–551PubMedCrossRefGoogle Scholar
  29. 29.
    Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P et al (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383–394PubMedCrossRefGoogle Scholar
  30. 30.
    Pinto A, De Carvalho M, Evangelista T, Lopes A, Sales-Luis L et al (2003) Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 4:31–35PubMedCrossRefGoogle Scholar
  31. 31.
    Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM et al (2007) Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler 8:185–188PubMedCrossRefGoogle Scholar
  32. 32.
    Jackson CE, Rosenfeld J, Moore DH, Bryan WW, Barohn RJ, Wrench M, Myers D, Heberlin L, King R, Smith J, Gelinas D, Miller RG et al (2001) A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 191:75–78PubMedCrossRefGoogle Scholar
  33. 33.
    Lechtzin N 2006 Respiratory effects of amyotrophic lateral sclerosis: problems and solutions. Respir Care 51:871–881; (discussion 881–884)Google Scholar
  34. 34.
    Bach JR (2002) Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. Chest 122:92–98PubMedCrossRefGoogle Scholar
  35. 35.
    Bach JR, Bianchi C, Aufiero E (2004) Oximetry and indications for tracheotomy for amyotrophic lateral sclerosis. Chest 126:1502–1507PubMedCrossRefGoogle Scholar
  36. 36.
    Pinto AC, Alves M, Nogueira A, Evangelista T, Carvalho J, Coelho A, de Carvalho M, Sales-Luis ML et al (1999) Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci 169:69–75PubMedCrossRefGoogle Scholar
  37. 37.
    Pinto AC, Evangelista T, de Carvalho M, Paiva T, de Lurdes Sales-Luis M et al (1999) Respiratory disorders in ALS: sleep and exercise studies. J Neurol Sci 169:61–68PubMedCrossRefGoogle Scholar
  38. 38.
    Wyatt J, Bellis F (2002) British Thoracic Society guidelines on non-invasive ventilation. Emerg Med J 19:435CrossRefGoogle Scholar
  39. 39.
    Jackson CE, Lovitt S, Gowda N, Anderson F, Miller RG et al (2006) Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler 7:80–85PubMedCrossRefGoogle Scholar
  40. 40.
    Babu KS, Chauhan AJ (2003) Non-invasive ventilation in chronic obstructive pulmonary disease. Bmj 326:177–178PubMedCrossRefGoogle Scholar
  41. 41.
    Baydur A, Layne E, Aral H, Krishnareddy N, Topacio R, Frederick G, Bodden W et al (2000) Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review. Thorax 55:4–11PubMedCrossRefGoogle Scholar
  42. 42.
    Aghai ZH, Saslow JG, Nakhla T, Milcarek B, Hart J, Lawrysh-Plunkett R, Stahl G, Habib RH, Pyon KH et al (2006) Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to nasal continuous positive airway pressure (NCPAP). Pediatr Pulmonol 41:875–881PubMedCrossRefGoogle Scholar
  43. 43.
    Achour L, Letellier C, Cuvelier A, Verin E, Muir JF et al (2007) Asynchrony and cyclic variability in pressure support noninvasive ventilation. Comput Biol Med 37:1308–1320PubMedCrossRefGoogle Scholar
  44. 44.
    Lujan M, Moreno A, Veigas C, Monton C, Pomares X, Domingo C et al (2007) Non-invasive home mechanical ventilation: effectiveness and efficiency of an outpatient initiation protocol compared with the standard in-hospital model. Respir Med 101:1177–1182PubMedCrossRefGoogle Scholar
  45. 45.
    Work group recommendations (2003) 2002 Exercise and Physical Activity Conference, St. Louis, Missouri. Session V: evidence of benefit of exercise and physical activity in arthritis. Arthritis Rheum 49:453–454Google Scholar
  46. 46.
    McCarthy WJ, Kuo T (2009) Support for benefit of physical activity on satiety, weight control, and diabetes risk. Arch Intern Med 169: 634–635; author reply 635Google Scholar
  47. 47.
    Press V, Freestone I, George CF (2003) Physical activity: the evidence of benefit in the prevention of coronary heart disease. QJM 96:245–251PubMedCrossRefGoogle Scholar
  48. 48.
    Fiatarone MA, O’Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ et al (1994) Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 330:1769–1775PubMedCrossRefGoogle Scholar
  49. 49.
    DeLateur BJ, Lehmann JF, Giaconi R (1976) Mechanical work and fatigue: their roles in the development of muscle work capacity. Arch Phys Med Rehabil 57:319–324PubMedGoogle Scholar
  50. 50.
    Aboussouan LS (2009) Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease. Chron Respir Dis 6:231–249PubMedGoogle Scholar
  51. 51.
    Abresch RT, Han JJ, Carter GT (2009) Rehabilitation management of neuromuscular disease: the role of exercise training. J Clin Neuromuscul Dis 11:7–21PubMedCrossRefGoogle Scholar
  52. 52.
    Adornato BT (1979) Exercise and neuromuscular disease. West J Med 131:334–335PubMedGoogle Scholar
  53. 53.
    Florence JM, Hagberg JM (1984) Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc 16:460–465PubMedCrossRefGoogle Scholar
  54. 54.
    Kilmer DD (1998) The role of exercise in neuromuscular disease. Phys Med Rehabil Clin N Am 9:115–125, viGoogle Scholar
  55. 55.
    Krivickas LS (2003) Exercise in neuromuscular disease. J Clin Neuromuscul Dis 5:29–39PubMedCrossRefGoogle Scholar
  56. 56.
    Chen A, Montes J, Mitsumoto H (2008) The role of exercise in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 19: 545–557, ix–xGoogle Scholar
  57. 57.
    de Carvalho M, Nogueira A, Pinto A, Miguens J, Sales Luis ML (1999) Reflex sympathetic dystrophy associated with amyotrophic lateral sclerosis. J Neurol Sci 169:80–83PubMedCrossRefGoogle Scholar
  58. 58.
    Sanjak M, Paulson D, Sufit R, Reddan W, Beaulieu D, Erickson L, Shug A, Brooks BR et al (1987) Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology 37:1217–1220PubMedGoogle Scholar
  59. 59.
    Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD et al (2001) The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 191:133–137PubMedCrossRefGoogle Scholar
  60. 60.
    Hakkinen A, Hakkinen K, Hannonen P et al (1994) Effects of strength training on neuromuscular function and disease activity in patients with recent-onset inflammatory arthritis. Scand J Rheumatol 23:237–242PubMedCrossRefGoogle Scholar
  61. 61.
    Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM et al (1993) Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 74:711–715PubMedCrossRefGoogle Scholar
  62. 62.
    Gozal D, Thiriet P (1999) Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception. Med Sci Sports Exerc 31:1522–1527PubMedCrossRefGoogle Scholar
  63. 63.
    Kilmer DD (2002) Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 81:S121–S126PubMedCrossRefGoogle Scholar
  64. 64.
    Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM et al (1994) The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 75:560–563PubMedGoogle Scholar
  65. 65.
    Sanjak M, Reddan W, Brooks BR (1987) Role of muscular exercise in amyotrophic lateral sclerosis. Neurol Clin 5:251–268, viGoogle Scholar
  66. 66.
    Longstreth WT, Nelson LM, Koepsell TD, Van Belle G et al (1991) Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis. Med Hypotheses 34:144–148PubMedCrossRefGoogle Scholar
  67. 67.
    Brooks BR, Miller RG, Swash M, Munsat TL et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299PubMedCrossRefGoogle Scholar
  68. 68.
    Mitchell JD (2000) Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)—from diagnosis to patient care. J Neurol 247:7–12PubMedCrossRefGoogle Scholar
  69. 69.
    Sinaki M, Mulder DW (1978) Rehabilitation techniques for patients with amyotrophic lateral sclerosis. Mayo Clin Proc 53:173–178PubMedGoogle Scholar
  70. 70.
    DeLisa JA, Mikulic MA, Miller RM, Melnick RR et al (1979) Amyotrophic lateral sclerosis: comprehensive management. Am Fam Physician 19:137–142PubMedGoogle Scholar
  71. 71.
    Bohannon RW (1983) Results of resistance exercise on a patient with amyotrophic lateral sclerosis. A case report. Phys Ther 63:965–968PubMedGoogle Scholar
  72. 72.
    Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT et al (2003) Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 53:804–807PubMedCrossRefGoogle Scholar
  73. 73.
    Dalbello-Haas V, Florence JM, Krivickas LS (2008) Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev CD005229Google Scholar
  74. 74.
    Cheah BC, Boland RA, Brodaty NE, Zoing MC, Jeffery SE, McKenzie DK, Kiernan MC (2009) INSPIRATIonAL—INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10(5–6):384–392Google Scholar
  75. 75.
    Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, Lecolle S, Lopes P, Vidal PP, Chanoine C, Charbonnier F et al (2009) Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol 587:3561–3572PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • J. P. Lopes de Almeida
    • 1
    • 2
    • 5
  • R. Silvestre
    • 3
  • A. C. Pinto
    • 1
    • 2
  • M. de Carvalho
    • 2
    • 4
  1. 1.Department of Physical Medicine and RehabilitationUniversity of Lisbon Medical School, Santa Maria HospitalLisbonPortugal
  2. 2.Neuromuscular Unit, Institute of Molecular MedicineUniversity of Lisbon Medical SchoolLisbonPortugal
  3. 3.Faculty of Physical Education and SportUniversidade Lusófona de Humanidades e TecnologiasLisbonPortugal
  4. 4.Department of NeurosciencesUniversity of Lisbon Medical School, Santa Maria HospitalLisbonPortugal
  5. 5.Clínica Universitária de Medicina Física e de Reabilitação, Faculdade de Medicina de LisboaHospital de Santa MariaLisboaPortugal

Personalised recommendations